Basit öğe kaydını göster

Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer

dc.contributor.authorDelanoy, Nicolas
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorRouge, Thibault de La Motte
dc.contributor.authorElaidi, Reza-Thierry
dc.contributor.authorOudard, Stephane
dc.contributor.authorAngelergues, Antoine
dc.contributor.authorMaillet, Denis
dc.contributor.authorFlechon, Aude
dc.contributor.authorMercier, Florence
dc.contributor.authorGuillot, Aline
dc.contributor.authorLe Moulec, Sylvestre
dc.contributor.authorGravis, Gwenaelle
dc.contributor.authorBeuzeboc, Philippe
dc.contributor.authorMassard, Christophe
dc.contributor.authorFizazi, Karim
dc.date.accessioned2021-03-06T10:33:41Z
dc.date.available2021-03-06T10:33:41Z
dc.date.issued2014
dc.identifier.citationAngelergues A., Maillet D., Flechon A., Ozguroglu M., Mercier F., Guillot A., Le Moulec S., Gravis G., Beuzeboc P., Massard C., et al., "Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer", EUROPEAN JOURNAL OF CANCER, cilt.50, ss.1602-1609, 2014
dc.identifier.issn0959-8049
dc.identifier.othervv_1032021
dc.identifier.otherav_eaecd86f-f5d8-4e09-80ae-44098d5680f0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/154304
dc.identifier.urihttps://doi.org/10.1016/j.ejca.2014.03.015
dc.description.abstractBackground: A prostate-specific antigen (PSA) flare occurs in about 15% of metastatic castration-resistant prostate cancer (mCRPC) patients receiving docetaxel. This flare has no standard definition. Its impact on treatment efficacy is unclear. We sought to evaluate the incidence and characteristics of PSA flare on cabazitaxel, and its impact on survival.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleProstate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF CANCER
dc.contributor.departmentAssistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume50
dc.identifier.issue9
dc.identifier.startpage1602
dc.identifier.endpage1609
dc.contributor.firstauthorID44100


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster